Interaction of cis-diamminedichloroplatinum (II) with single-stranded DNA in the presence or absence of escherichia coli singlestranded binding protein-Reference-Cited by-同舟云学术

Interaction of cis-diamminedichloroplatinum (II) with single-stranded DNA in the presence or absence of escherichia coli singlestranded binding protein

Published:1991-09 Issue:7 Volume:42 Page:1393-1398
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Hoffmann Jean-Sébastien,Hübscher Ulrich,Michot Bernard,Villani Giuseppe

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference28 articles.

1. Metal antitumor compounds: the mechanism of action of platinum complexes;Johnson;Prog Clin Biochem Med,1989

2. Binding of the antitumor drug cis-diamminedichloro-platinum(II) (cisplatin) to DNA;Pinto;Biochim Biophys Acta,1985

3. The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes;Eastman;Pharmac Ther,1987

4. Reevaluation of interaction of cis-dichloro(ethylenediamine) platinum(II) with DNA;Eastman;Biochemistry,1986

5. Mechanism of the reaction between cis-[PtCl2(NH3)2] and DNA in vitro;Johnson;J Am Chem Soc,1985

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spermine Attenuates the Action of the DNA Intercalator, Actinomycin D, on DNA Binding and the Inhibition of Transcription and DNA Replication;PLoS ONE;2012-11-08

2. Correlation of UV-induced mutational spectra and the in vitro damage distribution at the human hprt gene;Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis;1998-07

3. Differences in in vivo and in vitro sequence-specific sites of cisplatin-DNA adduct formation and detection of a dose-response relationship;Biochemical Pharmacology;1994-07

4. Molecular Aspects of Platinum-DNA Interactions;Molecular Aspects of Anticancer Drug-DNA Interactions;1993

5. In vitro DNA synthesis by DNA polymerase I and DNA polymerase α on single-stranded DNA containing either purine or pyrimidine monoadducts;Biochemical Pharmacology;1992-09